HomeMEHCQ • OTCMKTS
add
Chrome Holding Co
Nakaraang pagsara
$3.60
Sakop ng araw
$3.45 - $3.57
Sakop ng taon
$0.47 - $6.21
Market cap
96.40M USD
Average na Volume
125.12K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 25.42M | -37.10% |
Gastos sa pagpapatakbo | 44.24M | -43.21% |
Net na kita | -23.83M | 65.67% |
Net profit margin | -93.74 | 45.41% |
Kita sa bawat share | — | — |
EBITDA | -28.49M | 46.78% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 39.83M | -76.57% |
Kabuuang asset | 144.33M | -60.79% |
Kabuuang sagutin | 187.19M | -16.64% |
Kabuuang equity | -42.86M | — |
Natitirang share | 27.54M | — |
Presyo para makapag-book | -2.31 | — |
Return on assets | -50.47% | — |
Return on capital | 438.85% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -23.83M | 65.67% |
Cash mula sa mga operasyon | -28.99M | 33.00% |
Cash mula sa pag-invest | -1.03M | 10.64% |
Cash mula sa financing | 24.28M | 269,711.11% |
Net change in cash | -5.74M | 87.07% |
Malayang cash flow | 22.86M | 281.90% |
Tungkol
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously confrontational relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Itinatag
Abr 2006
Headquarters
Website
Mga Empleyado
261